 Abraham Nussbaum
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physician-Patient Relations | 6 | 2020 | 570 | 1.400 |
Why?
| | Religion and Medicine | 3 | 2019 | 32 | 1.340 |
Why?
| | Psychiatry | 3 | 2020 | 182 | 1.180 |
Why?
| | Depressive Disorder, Major | 3 | 2020 | 367 | 1.090 |
Why?
| | Antipsychotic Agents | 5 | 2017 | 195 | 1.090 |
Why?
| | Isoxazoles | 3 | 2012 | 53 | 1.040 |
Why?
| | Marijuana Smoking | 3 | 2014 | 254 | 0.960 |
Why?
| | Internship and Residency | 3 | 2024 | 1159 | 0.920 |
Why?
| | Clergy | 3 | 2019 | 11 | 0.910 |
Why?
| | Mental Disorders | 4 | 2020 | 1076 | 0.890 |
Why?
| | Literature, Modern | 2 | 2014 | 2 | 0.880 |
Why?
| | Schizophrenia | 4 | 2012 | 441 | 0.840 |
Why?
| | Spirituality | 1 | 2024 | 88 | 0.800 |
Why?
| | Palmitates | 2 | 2012 | 18 | 0.770 |
Why?
| | Vaccination Refusal | 2 | 2020 | 69 | 0.770 |
Why?
| | Medical Marijuana | 2 | 2014 | 120 | 0.760 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2020 | 238 | 0.730 |
Why?
| | Faith-Based Organizations | 1 | 2021 | 3 | 0.710 |
Why?
| | Medicine in Literature | 3 | 2016 | 3 | 0.690 |
Why?
| | Vaccination | 3 | 2020 | 1426 | 0.690 |
Why?
| | Cannabis | 3 | 2020 | 496 | 0.670 |
Why?
| | Marijuana Abuse | 2 | 2014 | 224 | 0.660 |
Why?
| | Physicians | 4 | 2024 | 918 | 0.620 |
Why?
| | Mass Vaccination | 1 | 2019 | 18 | 0.610 |
Why?
| | Philosophy, Medical | 1 | 2018 | 7 | 0.600 |
Why?
| | Smallpox | 1 | 2018 | 10 | 0.600 |
Why?
| | Smallpox Vaccine | 1 | 2018 | 23 | 0.600 |
Why?
| | Occupations | 1 | 2018 | 50 | 0.590 |
Why?
| | Motivational Interviewing | 1 | 2020 | 113 | 0.580 |
Why?
| | Professional Role | 1 | 2019 | 166 | 0.540 |
Why?
| | Hospitals, Psychiatric | 1 | 2017 | 27 | 0.540 |
Why?
| | Psychotic Disorders | 2 | 2017 | 169 | 0.530 |
Why?
| | Psychiatric Department, Hospital | 1 | 2016 | 13 | 0.490 |
Why?
| | Dronabinol | 3 | 2017 | 234 | 0.480 |
Why?
| | Inpatients | 2 | 2017 | 499 | 0.480 |
Why?
| | Leadership | 2 | 2019 | 395 | 0.470 |
Why?
| | Prescription Drug Diversion | 1 | 2014 | 12 | 0.450 |
Why?
| | Phytotherapy | 2 | 2013 | 83 | 0.440 |
Why?
| | Attitude to Death | 1 | 2014 | 68 | 0.430 |
Why?
| | Patient Readmission | 2 | 2017 | 698 | 0.420 |
Why?
| | Marijuana Use | 1 | 2017 | 206 | 0.410 |
Why?
| | Legislation, Drug | 1 | 2014 | 81 | 0.410 |
Why?
| | Practice Patterns, Physicians' | 2 | 2020 | 1292 | 0.400 |
Why?
| | Religion and Psychology | 1 | 2012 | 27 | 0.390 |
Why?
| | Writing | 1 | 2014 | 98 | 0.380 |
Why?
| | Psychoanalytic Therapy | 1 | 2011 | 10 | 0.370 |
Why?
| | Length of Stay | 1 | 2017 | 1204 | 0.360 |
Why?
| | Plant Preparations | 1 | 2011 | 36 | 0.360 |
Why?
| | Mental Health | 2 | 2020 | 724 | 0.350 |
Why?
| | Depression | 1 | 2020 | 1443 | 0.350 |
Why?
| | Drug Approval | 1 | 2011 | 86 | 0.340 |
Why?
| | Communication | 1 | 2016 | 910 | 0.330 |
Why?
| | Prescription Drugs | 1 | 2011 | 113 | 0.320 |
Why?
| | Humans | 27 | 2024 | 136960 | 0.320 |
Why?
| | Residence Characteristics | 1 | 2012 | 360 | 0.310 |
Why?
| | Antidepressive Agents | 1 | 2011 | 240 | 0.310 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2070 | 0.280 |
Why?
| | Suicide, Attempted | 1 | 2011 | 382 | 0.280 |
Why?
| | Mental Health Services | 1 | 2012 | 423 | 0.270 |
Why?
| | Paliperidone Palmitate | 3 | 2012 | 3 | 0.270 |
Why?
| | Suicide | 1 | 2014 | 656 | 0.260 |
Why?
| | Colorado | 5 | 2020 | 4515 | 0.240 |
Why?
| | Curriculum | 2 | 2024 | 1002 | 0.240 |
Why?
| | Alzheimer Disease | 1 | 2011 | 567 | 0.230 |
Why?
| | Courage | 1 | 2024 | 3 | 0.220 |
Why?
| | History, 20th Century | 2 | 2018 | 323 | 0.220 |
Why?
| | Pyrimidines | 1 | 2008 | 469 | 0.220 |
Why?
| | Cultural Competency | 1 | 2024 | 87 | 0.210 |
Why?
| | History, 21st Century | 2 | 2014 | 211 | 0.190 |
Why?
| | Risperidone | 2 | 2012 | 30 | 0.180 |
Why?
| | Education, Medical | 2 | 2016 | 268 | 0.180 |
Why?
| | Internal Medicine | 1 | 2024 | 265 | 0.180 |
Why?
| | Living Wills | 1 | 2020 | 8 | 0.170 |
Why?
| | Refusal to Treat | 1 | 2020 | 16 | 0.170 |
Why?
| | Observer Variation | 1 | 2020 | 341 | 0.160 |
Why?
| | Freedom | 1 | 2019 | 14 | 0.160 |
Why?
| | Vaccination Coverage | 1 | 2020 | 89 | 0.150 |
Why?
| | History, 18th Century | 1 | 2018 | 19 | 0.150 |
Why?
| | History, 19th Century | 1 | 2018 | 60 | 0.150 |
Why?
| | Science | 1 | 2018 | 53 | 0.140 |
Why?
| | Trust | 1 | 2019 | 140 | 0.140 |
Why?
| | Evidence-Based Practice | 1 | 2020 | 235 | 0.140 |
Why?
| | Anti-Anxiety Agents | 1 | 2017 | 43 | 0.130 |
Why?
| | Cues | 1 | 2019 | 316 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2012 | 1455 | 0.120 |
Why?
| | Public Health | 1 | 2021 | 588 | 0.120 |
Why?
| | Risk Factors | 3 | 2016 | 10367 | 0.120 |
Why?
| | Male | 6 | 2018 | 67419 | 0.110 |
Why?
| | Female | 7 | 2017 | 73054 | 0.110 |
Why?
| | Vaccines | 1 | 2019 | 400 | 0.100 |
Why?
| | Humanism | 1 | 2013 | 6 | 0.100 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 282 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2017 | 10715 | 0.100 |
Why?
| | Odds Ratio | 1 | 2016 | 1073 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3247 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1634 | 0.090 |
Why?
| | Physical Examination | 1 | 2013 | 239 | 0.090 |
Why?
| | Adult | 4 | 2017 | 37690 | 0.090 |
Why?
| | Psychoanalytic Interpretation | 1 | 2011 | 1 | 0.090 |
Why?
| | Dibenzothiazepines | 1 | 2011 | 17 | 0.090 |
Why?
| | Combined Modality Therapy | 2 | 2011 | 1218 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5802 | 0.090 |
Why?
| | Ethylene Glycol | 1 | 2011 | 15 | 0.090 |
Why?
| | Medicine | 1 | 2013 | 123 | 0.090 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 28 | 0.090 |
Why?
| | Drug Substitution | 1 | 2011 | 53 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1285 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2014 | 7596 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1613 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2016 | 642 | 0.080 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 104 | 0.080 |
Why?
| | Benzodiazepines | 1 | 2011 | 154 | 0.080 |
Why?
| | Suicidal Ideation | 1 | 2016 | 533 | 0.080 |
Why?
| | Middle Aged | 3 | 2017 | 33242 | 0.080 |
Why?
| | Sex Factors | 1 | 2016 | 2062 | 0.080 |
Why?
| | Quinolones | 1 | 2011 | 133 | 0.080 |
Why?
| | Pain | 2 | 2013 | 751 | 0.080 |
Why?
| | Young Adult | 2 | 2017 | 13202 | 0.080 |
Why?
| | Piperazines | 1 | 2011 | 345 | 0.070 |
Why?
| | United States | 3 | 2019 | 14894 | 0.070 |
Why?
| | Adolescent | 2 | 2020 | 21463 | 0.070 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 130 | 0.070 |
Why?
| | Prevalence | 1 | 2014 | 2732 | 0.070 |
Why?
| | Delayed-Action Preparations | 1 | 2008 | 173 | 0.070 |
Why?
| | Neuropsychological Tests | 1 | 2011 | 1043 | 0.060 |
Why?
| | Child, Preschool | 1 | 2020 | 10969 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1755 | 0.060 |
Why?
| | Prospective Studies | 1 | 2016 | 7511 | 0.050 |
Why?
| | State Government | 1 | 2019 | 46 | 0.040 |
Why?
| | Government Regulation | 1 | 2019 | 52 | 0.040 |
Why?
| | Pennsylvania | 1 | 2019 | 130 | 0.040 |
Why?
| | Attitude to Health | 1 | 2019 | 450 | 0.030 |
Why?
| | Aged | 1 | 2014 | 23838 | 0.030 |
Why?
| | Spasm | 1 | 2013 | 21 | 0.030 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2013 | 46 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1425 | 0.020 |
Why?
| | Quetiapine Fumarate | 1 | 2011 | 23 | 0.020 |
Why?
| | Aripiprazole | 1 | 2011 | 20 | 0.020 |
Why?
| | Pediatrics | 1 | 2019 | 1066 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2011 | 90 | 0.020 |
Why?
| | Cholesterol | 1 | 2011 | 410 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 366 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2011 | 547 | 0.020 |
Why?
| | Triglycerides | 1 | 2011 | 525 | 0.020 |
Why?
| | Risk | 1 | 2011 | 900 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1015 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 985 | 0.020 |
Why?
| | Body Mass Index | 1 | 2011 | 2422 | 0.010 |
Why?
| | Exercise | 1 | 2011 | 2074 | 0.010 |
Why?
| | Animals | 1 | 2013 | 36934 | 0.010 |
Why?
|
|
Nussbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|